“…At the same time, this collection reports many descriptions of newly characterized phages, which could be good candidates for the treatment of human infections due to Enterococcus faecalis [ 8 , 9 ], Klebsiella pneumoniae [ 10 ], Escherichia coli [ 11 ] and Pseudomonas aeruginosa [ 12 ] or to combat phytopathogens [ 13 , 14 ] or bacteria responsible for foodborne diseases [ 15 , 16 , 17 ]. It is relevant to underscore that, besides the use of standard techniques for general characterization of phages, some contributions evaluated their effective activity on bacterial biofilm [ 8 , 11 , 12 ] or on animal infection models [ 9 , 10 ], while others took original experimental approaches tailored to the future intended usage of the investigated phages [ 8 , 13 , 16 ].…”